Trial Outcomes & Findings for Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy (NCT NCT03380572)

NCT ID: NCT03380572

Last Updated: 2019-05-21

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

1 day

Results posted on

2019-05-21

Participant Flow

Participant milestones

Participant milestones
Measure
Senhance Cholecystectomy
Cholecystectomy operation performed using Senhance robotic system Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
Laparoscopic Cholecystectomy
Cholecystectomy operation performed using standard laparoscopic instruments Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
Overall Study
STARTED
20
20
Overall Study
COMPLETED
20
20
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
Total
n=40 Participants
Total of all reporting groups
Age, Continuous
45.9 years
STANDARD_DEVIATION 13 • n=20 Participants
48.4 years
STANDARD_DEVIATION 12.2 • n=20 Participants
46 years
STANDARD_DEVIATION 12 • n=40 Participants
Sex: Female, Male
Female
17 Participants
n=20 Participants
17 Participants
n=20 Participants
34 Participants
n=40 Participants
Sex: Female, Male
Male
3 Participants
n=20 Participants
3 Participants
n=20 Participants
6 Participants
n=40 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United Kingdom
20 participants
n=20 Participants
20 participants
n=20 Participants
40 participants
n=40 Participants

PRIMARY outcome

Timeframe: 1 day

Outcome measures

Outcome measures
Measure
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
Operative Time
86.5 minutes
Interval 60.5 to 106.5
31.5 minutes
Interval 26.0 to 41.0

SECONDARY outcome

Timeframe: 30 days

Outcome measures

Outcome measures
Measure
Senhance Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using Senhance robotic system Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
Laparoscopic Cholecystectomy
n=20 Participants
Cholecystectomy operation performed using standard laparoscopic instruments Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
Morbidity Data
3 Participants
5 Participants

Adverse Events

Senhance Cholecystectomy

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Laparoscopic Cholecystectomy

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Senhance Cholecystectomy
n=20 participants at risk
Cholecystectomy operation performed using Senhance robotic system Senhance Assisted Cholecystectomy: Cholecystectomy performed using Senhance surgical robotic system
Laparoscopic Cholecystectomy
n=20 participants at risk
Cholecystectomy operation performed using standard laparoscopic instruments Laparoscopic Cholecystectomy: Standard laparoscopic cholecystectomy
Skin and subcutaneous tissue disorders
Wound infection
5.0%
1/20 • Number of events 1 • 30 days
15.0%
3/20 • Number of events 3 • 30 days
Hepatobiliary disorders
Bile leak
0.00%
0/20 • 30 days
5.0%
1/20 • Number of events 1 • 30 days
Blood and lymphatic system disorders
Bleeding
5.0%
1/20 • Number of events 1 • 30 days
0.00%
0/20 • 30 days
General disorders
Pain
5.0%
1/20 • Number of events 1 • 30 days
5.0%
1/20 • Number of events 1 • 30 days

Additional Information

Mr R Aggarwal

Imperial College London

Phone: 02033126840

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place